Advertisement
Research Article

In Vivo Suppression of HIV by Antigen Specific T Cells Derived from Engineered Hematopoietic Stem Cells

  • Scott G. Kitchen mail,

    skitchen@ucla.edu

    Affiliation: Division of Hematology-Oncology, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Bernard R. Levin,

    Affiliation: Division of Hematology-Oncology, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Gregory Bristol,

    Affiliation: Division of Hematology-Oncology, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Valerie Rezek,

    Affiliation: Division of Hematology-Oncology, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Sohn Kim,

    Affiliation: Division of Hematology-Oncology, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Christian Aguilera-Sandoval,

    Affiliations: Department of Microbiology, Immunology, and Molecular Genetics, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, The UCLA AIDS Institute, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Arumugam Balamurugan,

    Affiliation: Division of Infectious Diseases, Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Otto O. Yang,

    Affiliations: Department of Microbiology, Immunology, and Molecular Genetics, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, The UCLA AIDS Institute, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Division of Infectious Diseases, Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Jerome A. Zack

    Affiliations: Division of Hematology-Oncology, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Department of Microbiology, Immunology, and Molecular Genetics, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, The UCLA AIDS Institute, The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

    X
  • Published: April 12, 2012
  • DOI: 10.1371/journal.ppat.1002649

Reader Comments (0)

Post a new comment on this article